Fluicell is proud to have an established portfolio of 3 products, to address researchers needs within the life sciences. Biopixlar is currently a big part of our focus, due to its huge potential. It is targeting a rapidly growing market with many potential applications (see question about the bioprinting market). Since we launched Biopixlar in November 2019, we have been actively marketing to both academic and industrial actors.
Biopixlar is a new and exciting platform within our portfolio,  Simultaneously, we also strive to further increase the sales of our other products. These 2 products have, over the last couple of years, been gaining in market traction and we are seeing an increase in the number of grant applications to purchase these platforms.